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RAPID COMMUNICATION
Activated (IL-2R+) intraglomerular mononuclear cells in
crescentic glomerulonephritis
HAI-LING Li, WAYNE W. HANCOCK, JOHN P. DOWLING, and ROBERT C. ATKINS
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Activated (IL-2R+) intraglomerular mononuclear cells in crescentic
glomerulouephritis. We recently reported evidence for the involvement
of local cellular immune activation in the immunopathogenesis of
human IgA nephropathy, particularly in cases of IgA disease featuring
crescent formation. In the current study, using monoclonal antibodies,
we investigated whether mononuclear cells bearing receptors for inter-
leukin 2 (IL-2R+ MNC) were present within glomeruli or associated
crescents in biopsies from patients with crescentic glomerulonephntis
(>60% crescents, N = 19), IgA disease with crescents (N = 9), or other
types of proliferative glomerulonephritis with crescents (10 to 44%, N =
6), compared with normal control kidneys (N = 10). Biopsies were
further classified into those showing active (cells, fibrin) (N = 15) or
inactive (sclerosed) crescents (N = 19), to determine whether IL-2R+
MNC were particularly associated with active crescent formation. Few
leucocytes were found within glomerular tufts of normal kidneys (2.4
0.7 cells/glomerular cross-section; mean SEM). By contrast, in
biopsies from patients with active crescentic glomerulonephritis, total
intraglomerular tuft leucocytes were increased to 14.0 1.7 (P < 0.01
vs. normal kidneys), largely due to increased numbers of intraglomer-
ular monocytes (10.4 1.1, P <0.01) and T cells (3.7 0.6, P <0.01).
Biopsies with active crescents also contained significantly increased
numbers of intraglomerular tuft IL-2R+ MNC (4.0 0.7, 29% of total
intraglomerular leucocytes), and there was a strong correlation between
the numbers of intraglomerular IL-2R+ MNC and T cells (P < 0.001).
Moreover, in this active crescentic group, increases in the numbers of
intraglomerular IL-2R+ MNC (P < 0.05), macrophages (P < 0.01) and
T cells (P < 0.01) were correlated with raised serum creatinine levels,
and the numbers of both IL-2R+ MNC (P < 0.05) and macrophages
(P< 0.01) correlated with decreased creatinine clearance. Patients with
inactive crescentic glomerulonephritis also showed increased levels of
tuft MNC compared to normal kidneys, but significantly less intraglo-
merular MNC than biopsies from patients with active crescentic dis-
ease. Thus, in inactive crescentic disease there was a four-fold increase
in glomerular MNC infiltration (total leucocytes 10.0 1.4, P < 0.01),
due to macrophages (6.6 1.0, P < 0.01 compared to normals or active
crescentic glomerulonephritis) and T cells (2.9 0.3, P < 0.01), and
including IL-2R+ MNC (2.2 0.3, P < 0.01 compared to normals or
active crescentic disease). The cellular composition of actual crescents
was also determined. Leucocytes contributed more than 60% of the
total cells within active crescents, due primarily to the presence of
macrophages (43.1% 5.1%) and T cells (7.1% 2.1%); 8% of these
leucocytes within crescents were IL-2R+. Glomeruli with active cres-
cents contained extensive ruptures of Bowman's capsules. Inactive
crescents, which generally displayed intact Bowman's capsules, pre-
sumeably as a result of fresh synthesis of basement membrane compo-
nents, contained fewer leucocytes (19.1% 2.2%), including reduced
numbers of macrophages (7.2% 1.9%) and T cells (0 to 3, ranges).
Given the close regulation of IL-2R expression on activated MNC, and
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the correlations observed between the presence of activated intraglo-
merular tuft MNC and decreased parameters of renal function, these
results suggest that crescent formation involves recruitment of macro-
phages to the glomerulus by sensitised T cells, analogous to events
occurring in a DTH response, and are consistent with a direct role for
cellular immunity in the immunopathogenesis and deteriorating renal
function characteristic of human crescentic glomerulonephritis.
Extensive analysis of experimental models of glomerulone-
phritis has resulted in considerable insights into the mecha-
nisms of immunologically induced glomerular injury. Individual
models based on antibody-mediated injury, immune complex
deposition or T cell-dependent glomerular damage are well
described. However, few studies have concerned identification
of similar mechanisms in human glomerulonephritis, particu-
larly T cell-dependent mechanisms (Type IV hypersensitivity
reactions). We recently reported that mononuclear cells bearing
receptors for interleukiri 2 (IL-2R+ MNC) were present in
significantly increased numbers in biopsies from patients with
IgA nephropathy with crescents, compared to patients with IgA
nephropathy without associated crescent formation or normal
controls [II. Moreover, the numbers of IL-2R+ MNC corre-
lated with raised serum creatinine and decreased creatinine
clearance, suggesting that local cellular immune activation is
involved in the immunopathogenesis of IgA disease, particu-
larly in cases with crescent formation.
The current study examined whether IL-2R+ MNC, T cells
and macrophages were present within glomeruli and/or associ-
ated crescents in a larger series of biopsies from patients with
more common forms of crescentic glomerulonephritis, and
more importantly, whether the presence of such activated MNC
was associated with deteriorating renal function.
Methods
Tissues
Renal biopsies from 19 patients with crescentic glomerulone-
phritis (> 60% crescents), were compared with biopsies from
nine patients with IgA nephropathy with crescents, and six
patients with other forms of proliferative glomerulonephritis
and focal crescent formation (10 to 44%) (Table 1). Biopsies
with predominantly fleshy, cellular crescents and associated
fibrin deposition were further classified as active crescents (N =
15), whereas those with largely organized, fibrous or fibrocel-
lular crescents and largely lacking fibrin deposits were classified
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Totals 34 19 15
Renal function
Serum creatinine, endogenous 24-hour creatinine clearance,
and glomerular filtration rate were determined in each patient at
the time of biopsy.
Statistical analysis
Data were analyzed on a personal computer using programs
from the CSS system (Statsoft, Tulsa, Oklahoma, USA). The
numbers of labelled cells in different groups were compared
using the two-tailed Student's t-test. The percentages of la-
belled cells within glomeruli or crescents in biopsies from
different groups were compared using a two-tailed Wilcoxon
Rank sum test, and correlations determined using Spearman's
test.
as inactive crescents (N 19) [2, 3]. Normal control tissues
consisted of portions of cadaver nephrectomies not used for
transplantation (N = 7) or kidneys removed because of local-
ized tumors (N = 3). All biopsies were routinely assessed by
light microscopy, immunofluorescence and electron micros-
copy, as well as by immunoperoxidase labelling using anti-
leucocyte and other monoclonal antibodies (mAbs). Specimens
for immunoperoxidase studies were fixed in PLP at 4°C, washed
in PBS containing 7% sucrose, snap frozen and stored at —80°C
until cryostat sectioning, as described previously [41.
Monoclonal antibodies
Infiltrating leucocytes were identified using the following
mAbs: all leucocytes—PHMI (CD45); all T cells—Leu 4 and
OKT3 (CD3); helper/inducer T cell subset—Leu 3A and OKT4
(CD4); cytotoxic/suppressor T cell subset—OKT8 (CD8); mac-
rophages-FMC32 (CD14); IL-2R+ MNC—Tac-l (CD25); B
cells—B 1 (CD2O), and NK cells—Leu 7 (CD57). Details of
these mAbs and their use were presented previously [5].
Biopsies were also labelled using a mAb to glomerular parietal
and visceral epithelial cells (PHM5) 12, 61.
Immunoperoxidase labelling
Cryostat sections (4 m) were labelled using a four-layer
immunoperoxidase (PAP) technique (4).
Evaluation of immunostained sections
Renal biopsies were examined for the presence of labelled
cells within glomerular tufts and any associated glomerular
crescents; biopsies contained 3 to 20 glomeruli. Labelled cells
within each glomerulus were counted and results were ex-
pressed as the number of cells per glomerular cross section.
Labelled cells within glomerular crescents were expressed as a
percentage of total crescent cells. Cell counts were performed
three times to reduce counting errors, and quantitative analysis
of infiltrating MNC was performed independently and without
knowledge of clinical or histopathologic data. Data were also
expressed in terms of whether most crescentic glomeruli (>
75%) in a given biopsy retained intact Bowman's capsules, or
whether such capsules were predominantly intact [7]; this was
assessed by examination of silver-stained paraffin sections,
prepared at three different levels from each biopsy, and by
immunoperoxidase labelling with PHM5 mAb [6].
Results
Intraglomerular MNC
Few leucocytes were present in normal renal tissue (2.4 0.7
cells/glomerular cross section); these consisted of monocytes
(1.4 0.4) and lesser number of T cells (0.3, range 0.1 to 0.4)
(Table 2). No IL-2R+ cells were detected. In contrast, biopsies
from patients with active crescentic glomerulonephritis showed
increased intraglomerular leucocytes (14.0 1.7, P < 0,01),
including macrophages (10.4 1.1, P < 0.01), T cells (3.7
0.6, P < 0.01) of both CD4+ and CD8+ phenotypes (P < 0.01),
and IL-2R+ MNC (4.0 0.7, P < 0.01; Table 2). Moreover,
though the nature of IL-2R+ MNC was not directly established
in this study, there were strong correlations between the
numbers of intraglomerular IL-2R+ MNC and both T cells (r =
0.76, P < 0.001, Fig. 1) and macrophages (r = 0.75, P < 0.001,
Fig. 2). Furthermore, the numbers of infiltrating macrophages
and T cells were also highly correlated (r = 0.77, P < 0.001, Fig.
3). B cells and NK cells were rarely identified within glomeruli
of any group (< 0.1 cells/glomerular cross section).
Biopsies from patients with inactive crescentic glomerulone-
phritis also showed increased numbers of intraglomerular leu-
cocytes, though to a lesser extent than in active crescentic
disease (Table 2). Thus, glomeruli in patients with inactive
crescentic disease showed increased total leucocytes (10.0
1.4, P < 0.01 vs. normal), due to increases in macrophages (6.6
1.0, P < 0.01 compared to both normal and active crescentic
disease) and T cells (2.9 0.3, P <0.01 vs. normal) of both
CD4+ and CD8+ phenotypes, as well as IL-2R+ MNC (2.2
0.3, P < 0.01 compared to normal or active disease). The
numbers of intraglomerular total leucocytes, macrophages, T
cells and IL-2R+ MNC present in biopsies classified primarily
as crescentic glomcrulonephritis, or proliferative glomerulone-
phritis with associated crescent formation, were significantly
increased compared with our previously studied groups of
patients with IgA nephropathy with crescents (Fig. 4)111.
Cells in glomerular crescents
Leucocytes contributed some 60% of cells within crescents of
patients with active crescentic disease (N 15) (Table 3).
Macrophages were the main cell type identified, contributing
43.1% 5.1% of cells within active crescents, and in some
glomeruli up to 90% of crescent cells were macrophages. T cells
were also present (7.1% 2.1%), including both CD4+ (4.9%
0.7%) and CD8+ (2.5% 0.5%) phenotypes, and IL-2R+ MNC
Table 1. Histologic classification of renal biopsies
No. of % Inactive Active
Diagnosis biopsies Crescents crescentsa crescentsa
Immune complex GN 14 70—100% 6 8
IgA nephropathy 9 8—71 % 8
Focal proliferative ON 4 35—44 % 2 2
Idiopathic GN 3 70—100% 1 2
Anti-GBM disease 2 60—100% 0 2
Pyelonephritis 1 30% 1 0
Membranoproliferative GN 1 10% 1 0
a As defined in Methods
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Table 2. Intraglomerular tuft MNC in biopsies from patients with crescentic glomerulonephritis (N = 34) versus normal kidneys (N= 10)
Group No. Total WBC Monocytes T cells
CD4+
cells
CD8+
cells
IL-2R+
cells
Normal kidneys 10 2.4a 0.7 1.4 0.4 03b
(0.1—0.4)
0.1
(0.1—0.2)
0.1
(0.1—0.2)
0.0
Inactive crescentse 19 10.0" 1.4 6.6C 1.0 2.9" 0.3 1.6" 0.5 l.2C 0.2 2.2" 0.3
Active crescentse 15 14.0" 1.7 104c.d 1.1 3.7" 0.6 27c.d 0.4 1.8" 0.3 4.0"" 0.7
a Expressed as cells/glomerular cross section (mean SEM)' Ranges are shown when numbers were very small
P < 0.01, between normal and crescentic glomerulonephritis
d P < 0.05, between inactive and active crescentic glomerulonephritis
as defined in Methods
(5.0% 1.4%). No crescent cells expressed B cell or NK cell
markers.
Nineteen patients with older, scierosed crescents were stud-
ied (Table 3). In contrast to biopsies with active, cellular
crescents, the proportion of leucocytes in scierosed crescents
was reduced to 19.1% 2.2% (P < 0.01), consisting of
macrophages (7.2% 1.9%, P <0.01) and only very few T cells
(range of 0 to 3%, P < 0.01) or IL-2R+ MNC (range of 0 to 2%,
P < 0.01). Morphologically, most crescent cells at this stage
appeared to be fibroblastoid or epithelioid in nature. The
influence of the integrity of Bowman's capsule on the compo-
sition of crescent cells was also considered (Table 4). For each
leucocyte population, the numbers of leucocytes within glomer-
uli with ruptured capsules were significantly greater (P < 0.01)
than in those with intact capsules.
Correlation between intro glomerular leucocytes and
decreased renal function
Intraglomerular MNC infiltration was strongly associated
with decreased renal function (Table 5). Thus, the numbers of
total leucocytes (P < 0.01), monocytes (P < 0.01), T cells (P <
0.01) and IL-2R+ MNC (P < 0.05) were each correlated with
increased serum creatinine, and the numbers of total leucocytes
(P < 0.05), macrophages (P < 0.01) and IL-2R+ MNC (P <
0.05) were correlated with decreased creatinine clearance.
However, none of these cells were correlated with urinary
protein or RBC excretion.
Discussion
This study investigated the contribution of leucocyte infiltra-
tion to the glomerular hypercellularity, accumulation of cells in
Bowman's space, and associated decreased renal function
characteristic of the various forms of human crescentic glomer-
ulonephritis [31. We found that essentially all biopsies from
patients with crescentic glomerulonephritis, regardless of etiol-
ogy, but particularly those with active disease, showed signifi-
cantly increased numbers of intraglomerular tuft leucocytes,
consisting predominantly of macrophages and lesser numbers
of T cells. Moreover, the findings that in active disease over
25% of these tuft leucocytes showed evidence of immune
activation (Table 2), as indicated by expression of IL-2R, and
that the presence of these cells correlated with decreased renal
function (Table 5), were consistent with the developing concept
that MNC activation is important to the immunopathogenesis of
human crescentic glomerulonephritis.
Since our initial report [8], using glomerular culture, of
macrophage infiltration of glomeruli from patients with crescen-
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Fig. 2. Correlation between the number of intro glomerular macro-
phages and JL-2R+ MNC in active crescent disease, determined by
Spearman's test.
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Fig. 1. Correlation between the number of intraglomerular T cells and
IL-2R+ MNC in active crescentic disease, determined by Spearman's
test.
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tic glomerulonephritis, a number of groups have confirmed that
leucocytes contribute to the glomerular hypercellularity usually
found in this group of diseases [reviewed in 31. Other groups
[9—111 have also reported that, based on the use of mAbs, small
numbers of T cells accompany the more prominent influx of
macrophages into the glomerulus during crescentic glomerulo-
nephritis. However, the new and more important finding of the
current study was the demonstration that many of these MNC
expressed IL-2R, a receptor whose induction and transient
expression play a key role in T cell activation [121.
In fact, a variety of leucocytes are now known to be capable
of expressing IL-2R. However, with relevance to the present
study, IL-2R are expressed upon activation of both T cells and
macrophages, but are absent from resting cells. T cells recog-
nize antigens located on the surfaces of Class Il-bearing mac-
rophages, and in the presence of IL-i, undergo rapid activation
with induction of IL-2R, and production of a panopoly of
biologically active cytokines, but notably IL-2, required for
clonal expansion of activated T cells [121, and interferon-
gamma, a potent activator of macrophages [13]. Macrophages
can themselves be activated by IL-2 or interferon-gamma to
transiently express IL-2R [14, 151, and indeed, IL-2R+ macro-
phages are found in a variety of human diseases involving T
cell-dependent immune responses, including allograft rejection
[16] and sarcoidosis [17]. Hence, in the absence of double
labelling studies, it was unclear whether intraglomerular IL-
2R+ MNC detected in the current study were actually activated
T cells, macrophages or a mixture of both cell types; statisti-
cally, the presence of both cell types was strongly correlated
with IL-2R+ MNC, as well as with each other, and the
morphologic features of IL-2R+ MNC in cryostat sections were
indistinct. In addition, we have previously reported that intra-
glomerular macrophages in biopsies from patients with crescen-
tic glomeruionephritis expressed the procoagulant molecule,
tissue factor, and that such procoagulant expression was
closely associated with the fibrin deposition generally found in
these patients [181. Since induction of macrophage tissue factor
expression is controlled by cytokine(s) produced locally by
activated helper T cells [19], the current results suggest a
possible source of cytokine(s) for such macrophage activation.
Following activation, both IL-2R+ T cells and macrophages
shed IL-2R into surrounding fluids, and measurement of soluble
IL-2R levels is currently used for monitoring of a number of
diseases with an immunologic basis [121. Yorioka et al [201 have
recently reported that serum IL-2R levels were significantly
elevated in 55 patients with noncrescentic glomerulonephritis,
including IgA nephropathy, membranous glomerulonephritis
and mesangial proliferative glomerulonephritis, compared to
healthy controls. Soluble IL-2R levels correlated with serum
creatininc and decreased creatinine clearance [201. The current
results, combined with our previous report of IL-2R+ MNC
within glomeruli of patients with crescentic IgA disease [1],
indicate that the presence of increased serum IL-2R levels may
reflect, at least in part, local immune activation and IL-2R
induction on MNC within damaged glomeruli.
The basis for the correlations between increased numbers of
intraglomerular macrophages, T cells and IL-2R+ MNC and
increased serum creatinine and decreased creatinine clearance
in these patients is unknown. However, it is of interest that
glomerular cell cultures from patients with crescentic glomeru-
lonephritis contain significant levels of IL-i [211, and that the
binding of IL-2 to IL-2R+ human macrophages is a potent
inducer of IL-i [22] and TNF [23] production. It is possible that
intraglomerular production of IL-i and TNF (or additional
cytokines) may be responsible, at least in part, for the de-
creased renal function, consistent with the effects o. these
cytokines on glomerular mesangial [241 and endothelial cells
[25—271 in vitro and in vivo.
Conversely, the decreased renal function may simply result
from disruption of normal glomerular filtration due to accumu-
lation and proliferation of cells in Bowman's space. We found
that some 60% of crescent cells during active disease were
leucocytes, consistent with our previous findings [21, but that in
addition to a large proportion of macrophages, these cells
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phages and T cells, determined by Spearman's test.
Fig. 4. Numbers of intraglomerular total leucocytes and cell subsets
present in biopsies classified as IgA nephropathy with crescents (IgA),
other proliferative GN with crescents (GN), or crescentic GN (>60%
crescents, CGN). CGN and GN biopsies had significantly greater
numbers of intraglomerular total leucocytes (U), macrophages ( ), T
cells (NJ) and IL-2R+ MNC (U) than IgA biopsies (P < 0.05).
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Table 3. Leucocytes within crescents of biopsies from patients with active or inactive crescentic glomerulonephritisa
CD4+ CD8+
Group Total WBC Monocytes T cells cells cells
IL-2R+
cells
Active 60.5 50" 43.1 5.1" 7.1 2.1" 4.9 0.7" 2.5 05b(N= 15)
Inactive 19.1 2.2 7.2 1.9 0—3" 0—2 0—1
(N= 19)
5.0 14b
0—2
a Expressed as % of total crescent cells (mean SaM), and determined by immunoperoxidase labelling with mAbs.b p < 0.01, between active and inactive crescents
Ranges are shown when numbers very small
Table 4. Leucocytes within crescents of glomeruli with ruptured versus intact Bowman's capsules (BC)
CD4+ CD8+
Group No. Total WBC Monocytes T cells cells cells
IL-2R+
cells
Ruptured BC 20 635b 5.8 451b 55 75b 2.2 48b 0.9 27b 0.5
Intact BC 14 15.9 2.9 6.9 1.7 0—3" 0—1.5 0-0.8
55b 1.3
0—2
a Leucocytes determined by mAb labelling and expressed as % total crescent cells (mean 5EM); integrity of BC determined by evaluation of
silver-stained paraffin sections and/or by immunoperoxidase labelling with PHM5 mAb.
"P < 0.01, between groups with predominantly intact vs. ruptured BC
"Ranges are shown when numbers were very small
Table 5. Correlations between in traglomerular MNC and renal function in crescentic glomeronephritis (N = 34)
Renal function
parameter
Total
WBC Monocytes T cells
CD4+
cells
CD8+
cells
IL-2R+
cells
Serum creatinine r = 0.69
P < 0.01
Creatinine clearance r = —0.68
P < 0.05
Urine protein excretion NS
Urine RBC excretion NS
r = 0.68
P < 0.01
r =
—0.80
P < 0.01
NS
NS
r = 0.69
P < 0.01
NS
NS
NS
r = 0.62
P < 0.05
NS
NS
NS
r = 0.60
P < 0.05
NS
NS
NS
r = 0.61
P < 0.05
r =
—0.63
P < 0.05
NS
NS
included significantly increased numbers of T cells and IL-2R+
MNC, compared to inactive disease. Moreover, in agreement
with the results of Boucher et al [71, such increases were usually
accompanied by tears in Bowman's capsule (Table 4). Hence,
whether these leucocytes originate from within damaged tuft
capillaries, or migrate into Bowman's space through breaks in
the capsule, is unknown and warrants careful and serial analysis
using experimental models.
Current concepts of crescent formation suggest that egress of
MNC into Bowman's space may follow intense inflammation
within the tuft with release of proteolytic enzymes, superoxide
anions, and cytokines which damage the glomerular capillary
walls [31. Hence, continuance of an active immune response
within Bowman's space, as reflected by the content of IL-2R+
MNC in active disease, may contribute to this damage, for
example, by promoting macrophage production of IL-l and
TNF, and procoagulant activity. The latter suggestion is con-
sistent with knowledge that crescent macrophages express
tissue factor [18, 28], and the almost universal finding of fibrin
deposition within Bowman's space during active disease [3].
Moreover, -thrombin was recently reported to induce glomeru-
lar epithelial cell proliferation in vitro [29], suggesting a possible
link between the initial active phase of crescentic disease, when
T cell-induced macrophage activation and procoagulant expres-
sion may occur, and a later phase when crescents become
organized and contain significantly decreased numbers of mac-
rophages, as observed here, but increased proportions of epi-
thelial cells [3].
In summary, these studies indicate that activated MNC are
present within glomeruli and Bowman's space during active
human crescentic disease, and correlate with decreased renal
function, suggesting the importance of cellular immune activa-
tion to the evolution of crescentic glomerulonephritis. Further
studies are necessary to identify the precise nature of these
IL-2R+ MNC, and to determine, initially using experimental
models, whether targeting of this critical subpopulation of
activated MNC is relevant to the therapy of crescentic glomer-
ulonephritis, analogous to the successful abrogation of trans-
plant rejection achieved through the administration of anti-
IL-2R mAbs [16].
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